A. The following Books/References are of general interest
Caufield C (1990) Multiple Exposures: Chronicles of the Radiation Age. Penguin Books. London UK
Jean-Philippe Desbordes Atomic Park : A la recherche des victimes du nucléaire. Actes Sud, France 2006.
Greene G (1999) The Woman Who Knew Too Much. University of Michigan Press. Ann Arbor, MI, US.
Malley C., Marjorie (2011) Radioactivity: A History of a Mysterious Science, Oxford University Press. New York, US.
Proctor RN (1995) Cancer Wars: How Politics Shapes What We Know and Don’t Know about Radiation. Basic Books. New York, NY, US
Greenberg M (1991) The Evolution of Attitudes to the Human Hazards of Ionising Radiation and to its Investigators. Am J of Industrial Medicine Vol 20 pp 717-721
Rose G (1991) Environmental Health: Problems and Prospects. J of Royal College of Physicians of London Vol 25 No 1, pp 48-52
Stewart AM (1991) Evaluation of Delayed Effects of Ionising Radiation: an Historical Perspective. Am J of Industrial Medicine Vol 20 pp 805-810.
Annie Thébaud-Mony. (2011) Nuclear Servitude: Subcontracting and Health in the French Civil Nuclear Industry. Baywood Publishing Co Inc US
Tortured Science: Health Studies, Ethics and Nuclear Weapons in the United States. Edited by Dianne Quigley, Amy Lowman, and Steve Wing. Baywood Publishing Co, Inc US
B. References from the 2004 CERRIE Report (www.cerrie.org) on the radiation risks of internal emitters
Aghamohammadi S and Savage JR (1992). The effect of X-irradiation on cell cycle progression and chromatid aberrations in stimulated human lymphocytes using cohort analysis studies. Mutat Res, 268, 223–30.
Al-Achkar W, Sabatier L and Dutrillaux B (1988). Influence of time and cell cycle phase on radiationinduced chromosome lesions. Ann Genet, 31, 87–90.
Alexander FE, Cartwright RA, McKinney PA and Ricketts TJ (1990). Leukaemia incidence, social class and estuaries: an ecological analysis. J Public Health Med, 12, 109–17.
Apostoaei AI and Miller LF (2004). Uncertainties in dose coefficients from ingestion of 131I, 137Cs and 90Sr. Health Phys, 86, 460–82.
Archer VE (1987). Association of nuclear fallout with leukemia in the United States. Arch Environ Health, 42, 263–71.
Assinder DJ, Robinson CD, Halsall A and Telford J (1994). The distribution and behaviour of artificial radionuclides in sediments of the North Wales coast, UK. J Radioanal Nucl Chem, 182, 225–35.
Atkinson WD, Law DV and Bromley KJ (2002). A decline in the mortality from prostate cancer in the UKAEA workforce, In: Proceedings of the 4th International Conference on Health Effects of Low-level Radiation, September 2002, Oxford. Thomas Telford, London, Paper 08.
Auvinen A, Hakama M, Arvela H, Hakulinen T, Rabola T, Suomela M, et al (1994). Fallout from Chernobyl and incidence of childhood leukaemia in Finland, 1976–92. BMJ, 309, 151–4.
Bandazhevsky YI (1997). Structural and Functional Effects of Radioisotopes Incorporated by the Organism (ed YI
Bandazhevsky). Ministry of Health Care of Republic of Belarus, Belorussian Engineering Academy, Gomel State Medical Institute, Gomel.
Bandazhevsky YI (1998). Pathophysiology of Incorporated Radioactive Emission (ed YI Bandazhevsky). Gomel State Medical Institute, Gomel.
Bandazhevsky YI and Lelevich V (1995). Clinical and Experimental Aspects of the Effect of Incorporated Radionuclides upon the Organism (eds YI Bandazhevsky and V Lelevich). Ministry of Health of the Republic of Belarus, Belorussian Engineering Academy, Gomel State Medical Institute, Gomel.
Barber R, Plumb MA, Boulton E, Roux I and Dubrova YE (2002). Elevated mutation rates in the germ line of first- and second-generation offspring of irradiated male mice. Proc Natl Acad Sci USA, 99, 6877–82.
Barcellus-Hoff MH and Brooks AL (2001). Extracellular signalling via the microenvironment: a hypothesis relating to carcinogenesis, bystander effects and genomic instability. Radiat Res, 156, 618–27.
Beck U (1992). Risk Society: Towards a New Modernity. Sage, London.
Bingham D, Harrison JD and Phipps AW (1997). Biokinetics and dosimetry of chromium, cobalt, hydrogen, iron and zinc radionuclides in male reproductive tissues of the rat. Int J Radiat Biol, 72, 235–48.
Bingham D, Gardin I and Hoyes KP (2000). The problem of Auger emitters for radiological protection. In: Proceedings Workshop on Environmental Dosimetry, Avignon, September 1999. Radiat Prot Dosim, 92, 219–28.
Bithell JF and Stewart AM (1975). Pre-natal irradiation and childhood malignancy: a review of British data from the Oxford Survey. Br J Cancer, 31, 271–87.
Bithell JF, Dutton SJ, Draper GJ and Neary NM (1994). Distribution of childhood leukaemias and non-Hodgkin’s lymphomas near nuclear installations in England and Wales. BMJ, 309, 501–5.
Black Advisory Group (1984). Investigation of the Possible Increased Incidence of Cancer in West Cumbria. HMSO, London.
Black RJ, Urquhart JD, Kendrick SW, Bunch KJ, Warner J and Adams Jones D (1992). Incidence of leukaemia and other cancers in birth and schools cohorts in the Dounreay area. BMJ, 304, 1401–5.
Bois PR (2003). Hypermutable minisatellites, a human affair? Genomics, 81, 349–55.
Bolsch WE (1994). Physical and chemical interactions of radiation with living tissues. In: Internal
Radiation Dosimetry (ed OG Raabe). Medical Physics Publishing, Wisconsin, pp 27–40.
Bond VP (1981). The conceptual basis of evaluating risk from low-level radiation exposure. In: Critical Issues in Setting Radiation Protection Dose Limits. Proceedings of 17th Annual Meeting of the National Council on Radiation Protection and Measurements, April 1981. NCRP, Bethesda MD.
Bouffler SD, Haines JW, Edwards AA, Harrison JD and Cox R (2001). Lack of detectable transmissible chromosomal instability after in vivo or in vitro exposure of mouse bone marrow cells to 224Ra alpha particles. Radiat Res, 155, 345–52.
Boutou O, Guizard A-V, Slama R, Pottier D and Spira A (2002). Population mixing and leukaemia in young people around the La Hague nuclear waste reprocessing plant. Br J Cancer, 87, 740–45.
Bradley EJ and Ewings LW (1995). The transfer and resulting radiation dose from polonium, thorium and other naturally-occurring radionuclides to the human fetus. In: Health Effects of Internally Deposited Radionuclides: Emphasis on Radium and Thorium (eds G van Kaick, A Karaoglou and AM Kellerer). World Scientific, Singapore, pp 19–22.
Brain JD (1988). Lung macrophages: how many kinds are there? What do they do? Am Rev Respir Dis, 137, 507–9.
Brenner DJ and Sachs RK (2003). Domestic radon risks may be dominated by bystander effects – but the risks are unlikely to be greater than we thought. Health Phys, 85, 103–9.
Bridges BA (2001). Radiation and germline mutations at repeat sequences: are we in the middle of a paradigm shift? Radiat Res, 156, 631–41.
Broadway JA, Smith JM, Norwood DL and Porter CR (1988). Estimates of radiation dose and health risk to the United States population following the Chernobyl nuclear plant accident. Health Phys, 55, 533–9.
Brooks AL, Retherford JC and McClellan RO (1974). Effects of 239PuO2: particle number and size on size on the frequency and distribution of chromosome aberrations in the liver of the Chinese hamster. Radiat Res, 59, 693–709.
Brooks AL, Benjamin SA, Hahn FF, Brownstein DG, Griffith MW and McClellan RO (1983). The induction of liver tumors by 239Pu citrate or 239PuO2 particles in the Chinese hamster. Radiat Res, 96, 135–51.
Burlakova EB, Antova Yu S, Goloshchapov AN, Gurevich SM, Zhizhina GP, Kozachenko AI, et al
(1999). Mechanisms of biological action of low-dose irradiation. In: Consequences of the Chernobyl
Catastrophe on Human Health (ed EB Burlakova). Nova Science, Commack NY, pp 11–38. Busby C (1995). Wings of Death: Nuclear Pollution and Human Health. Green Audit Books, Aberystwyth.
Busby C (1996). Recalculating the second event error. http://www.llrc.org/secevnew.htm
Busby C and Scott Cato M (2000). Increases in leukaemia in infants in Wales and Scotland following Chernobyl: evidence for errors in statutory risk estimates. Energy Environ, 11, 127–39.
Busby C and Bramhall R (2002). Breast Cancer Mortality and Proximity to Bradwell Nuclear Power Station in Essex 1995–1999. Correction and Update to 2001 with a Commentary on Official Responses. Green Audit, Aberystwyth, Occasional Paper 2002/6.
Busby C and Rowe H (2002). Cancer in Burnham on Sea North: Results of the PCAH Questionnaire. Green Audit, Aberystwyth, Occasional Paper 2002/5.
Busby C, Kocjian B, Mannion E and Scott Cato M (1998). Proximity to the Irish Sea and Leukaemia incidence at ages 0–4 in Wales from 1974–1989. Green Audit, Aberystwyth, Occasional Paper 98/4.
Busby C, Dorfman P and Rowe H (2000). Cancer Mortality and Proximity to Hinkley Point Nuclear Power Station in Somerset, 1995–1998. Part 1 – Breast Cancer; Part 2 – Prostate Cancer; Part 3 – All Malignancy, Lung Cancer, Stomach Cancer and Summary of Results. Green Audit, Aberystwyth Occasional Papers 2000/2 and 2000/4.
Busby C, Dorfman P and Bramhall R (2001a). Environmental Risk Methodology and Breast Cancer Mortality near Bradwell Nuclear Power Station in Essex, 1995–1999. Green Audit, Aberystwyth, Occasional Paper 2001/8.
Busby C, Bramhall R and Dorfman P (2001b). Cancer Mortality and Proximity to Bradwell Nuclear Power Station in Essex, 1995–1999. Preliminary Results. Green Audit, Aberystwyth, Occasional Paper 2001/4A.
Calabrese EJ and Baldwin LA (2003). Toxicology rethinks its central belief. Nature, 421, 691–2.
Cameron J (2003). Paper INFO 7B prepared for CERRIE. See www.cerrie.org.
Cardis E, Gilbert ES, Carpenter L, Howe G, Kato I, Armstrong BK, Beral V, Cowper G, Douglas A, Fix J, et al (1995). Effects of low doses and low dose rates of external ionizing radiation: cancer mortality among nuclear industry workers in three countries. Radiat Res, 142, 117–32.
Chadwick KH, Leenhouts HP, Lahaij GMH and Venema LB (1995). The implications of a twomutation carcinogenesis model for internal emitters. In: Health Effects of Internally Deposited Radionuclides: Emphasis on Radium and Thorium (eds G van Kaick, A Karaoglou and AM Kellerer). World Scientific, Singapore, pp 353–60.
Charles MW, Mill AJ and Darley PJ (2003). Carcinogenic risk of hot particle exposures. J Radiol Prot, 23, 5–28.
Chuang YY and Liber HL (1996). Effects of cell cycle position on ionizing radiation mutagenesis. I. Quantitative assays of two genetic loci in a human lymphoblastoid cell line. Radiat Res, 146, 494–500.
Committee on Medical Aspects of Radiation in the Environment (COMARE) (1986). First Report. The implications of the new data on the releases from Sellafield in the 1950s for the conclusions of the report on the investigation of the possible increased incidence of cancer in West Cumbria. HMSO, London.
Committee on the Medical Aspects of Radiation in the Environment (COMARE) (1988). Second Report. Investigation of the possible increased incidence of leukaemia in young people near the Dounreay Nuclear Establishment, Caithness, Scotland. HMSO, London.
Committee on the Medical Aspects of Radiation in the Environment (COMARE) (1989). Third Report. Report on the incidence of childhood cancer in the West Berkshire and North Hampshire area, in which are situated the Atomic Weapons Research Establishment, Aldermaston and the Royal Ordnance Factory, Burghfield. HMSO, London.
Committee on the Medical Aspects of Radiation in the Environment (COMARE) (1996). Fourth Report. The incidence of cancer and leukaemia in young people in the vicinity of the Sellafield site, West Cumbria: further studies and an update of the situation since the publication of the report of the Black Advisory Group in 1984. Department of Health, London.
Committee on Medical Aspects of Radiation in the Environment (COMARE) (1999a). Sixth Report. A reconsideration of the possible health implications of the radioactive particles found in the general environment around the Dounreay Nuclear Establishment in the light of the work undertaken since 1995 to locate their source. NRPB, Chilton.
Committee on Medical Aspects of Radiation in the Environment (COMARE) (1999b). COMARE statement. Statement on the Incidence of Childhood Cancer in Wales.
Committee on Medical Aspects of Radiation in the Environment (COMARE) (2001). COMARE statement. Further Statement on the Incidence of Childhood Cancer in Wales.
Committee on the Medical Aspects of Radiation in the Environment (COMARE) (2002). Seventh Report. Parents occupationally exposed to radiation prior to the conception of their children. A review of the evidence concerning the incidence of cancer in their children. NRPB, Chilton.
Committee on the Medical Aspects of Radiation in the Environment (COMARE) (2003a). COMARE Statement on Green Audit Occasional Paper 2002/5 Cancer in Burnham on Sea North: Results of the PCAH (Parents Concerned About Hinkley) Questionnaire.
Committee on the Medical Aspects of Radiation in the Environment (COMARE) (2003b). COMARE statement. Cancer Mortality around the Bradwell Nuclear Power Station, Essex.
Committee on Medical Aspects of Radiation in the Environment (COMARE) (2004). Cancer in Burnham on Sea North: Results of the PCAH (Parents Concerned About Hinkley) Questionnaire. (http://www.comare.org.uk/statements/comare_statement_burnham.htm).
Connecticut Tumor Registry (2001). Cancer Incidence in Connecticut, 1999. Connecticut Department of Public Health, Hartford CT.
Cook-Mozaffari P, Darby S and Doll R (1989). Cancer near potential sites of nuclear installations. Lancet, ii, 1145–7.
Cox R and Edwards A (2002). Comments on the paper of Nakanishi et al (2001). Int J Radiat Biol, 78, 443–5.
Cucinotta FA, Nikjoo H and Goodhead DT (2000). Model for the radial dependence of frequency distribution for energy imparted in nanometer volumes from HZE particles. Radiat Res, 153, 459–68.
Darby SC and Doll R (1987). Fallout, radiation doses near Dounreay, and childhood leukaemia. BMJ, 294, 603–7.
Darby SC, Olsen JH, Doll R, Thakrar B, de Nully Brown P, Storm HH, et al (1992). Trends in childhood leukaemia in the Nordic countries in relation to fallout from atmospheric nuclear weapons testing. BMJ, 304, 1005–9.
De Nully Brown P, Hertz H, Olsen JH, Yssing M, Scheibel E and Jensen OM (1989). Incidence of childhood cancer in Denmark 1943–1984. Int J Epidemiol, 18, 546–55.
Desoye G, Hartmann M, Jones CJ, Wolf HJ, Kohnen G, Kosanke G and Kaufmann P (1997). Location of insulin receptors in the placenta and its progenitor tissues. Microsc Res Tech, 38, 63–75.
Dickinson HO and Parker L (1999). Quantifying the effect of population mixing on childhood leukaemia risk: the Seascale cluster. Br J Cancer, 81, 144–51.
Dickinson HO and Parker L (2002). Leukaemia and non-Hodgkin’s lymphoma in children of male Sellafield radiation workers. Int J Cancer, 99, 437–44.
Doll R (1964). In: Medical Surveys and Clinical Trials (ed LJ Witts), 2nd ed. London, p 333.
Doll R (1999). The Seascale cluster: a probable explanation. Br J Cancer, 81, 3–5.
Doll R and Hill AB (1964). Mortality in relation to smoking: 10 years’ observations of British doctors. BMJ, i, 1399–1410, 1460–67.
Draper GJ, Stiller CA, Cartwright RA, Craft AW and Vincent TJ (1993). Cancer in Cumbria and in the vicinity of the Sellafield nuclear installation, 1963–90. BMJ, 306, 89–94.
Dubrova YE and Plumb MA (2002). Ionising radiation and mutation induction at mouse minisatellite loci. The story of the two generations. Mutat Res, 499, 143–50.
Dubrova YE, Jeffreys AJ and Malashenko AM (1993). Mouse minisatellite mutations induced by ionising radiation. Nat Genet, 5, 92–4.
Dubrova YE, Nesterov VN, Krouchinsky NG, Ostapenko VA, Neumann R, Neil DL and Jeffreys AJ (1996). Human minisatellite mutation rate after the Chernobyl accident. Nature, 380, 683–6.
Dubrova YE, Nesterov VN, Krouchinsky NG, Ostapenko VA, Vergnaud G, Giraudeau F, Buard J and Jeffreys AJ (1997). Further evidence for elevated human minisatellite mutation rate in Belarus eight years after the Chernobyl accident. Mutat Res, 381, 267–78.
Dubrova YE, Plumb M, Brown J, Fennelly J, Bois P and Goodhead D (1998). State specificity, dose response, and doubling dose for mouse minisatellite germ-line mutation induced by acute radiation. Proc Natl Acad Sci USA, 95, 6251–5.
Dubrova YE, Plumb M, Brown J, Boulton E, Goodhead D and Jeffreys AJ (2000a). Induction of minisatellite mutations in the mouse germline by low-dose chronic exposure to gamma-radiation and fission neutrons. Mutat Res, 453, 17–24.
Dubrova YE, Plumb M, Gutierrez B, Boulton E and Jeffreys AJ (2000b). Transgenerational mutation by radiation. Nature, 405, 37.
Dubrova YE, Grant G, Chumak AA, Stezhka, VA and Karakasian AN (2002a). Elevated minisatellite mutation rate in the post-Chernobyl families from the Ukraine. Am J Hum Genet, 71, 801–9.
Dubrova YE, Bersimbaev RI, Djansugurova LB, Tankimanova MK, Mamyrbaev ZZ, Mustonen R, Lindholm, C, Hulten M and Salomaa S (2002b). Nuclear weapons tests and human germline mutation rate. Science, 295, 1037.
Dugan LC and Bedford JS (2003). Are chromosomal instabilities induced by exposure of cultured normal human cells to low- or high-LET radiation? Radiat Res, 159, 301–11.
Duncan D and Lawrence D (1991). Residual activation events functional after irradiation of mouse splenic lymphocytes. Radiat Res, 125, 6–13.
Dunster HJ (2003). The Society for Radiological Protection – 40 years on from 1963. J Radiol Prot, 23, 143–56.
Eakins JD and Lally AE (1984). The transfer to land of actinide-bearing sediments from the Irish Sea by spray. Sci Tot Environ, 35, 23–32.
Eckerman KF (1994). Dosimetric methodology of the ICRP. In: Internal Radiation Dosimetry (ed OG Raabe). Medical Physics Publishing, Wisconsin, pp 239–70.
ECRR (2003). 2003 Recommendations of the European Committee on Radiation Risk. Green Audit Press, Aberystwyth.
Edwards AA and Cox R (2000). Commentary on the second event theory of Busby. Int J Radiat Biol, 76, 119–25 (including correspondence with C Busby).
Ellegren H, Lindgren G, Primmer CR and Moller AP (1997). Fitness loss and germline mutations in barn swallows breeding in Chernobyl. Nature, 389, 593–6.
Ellinger I, Schwab M, Stefanescu A, Hunziker W and Fuchs R (1999). IgG transport across trophoblast-derived BeWo cells: a model system to study IgG transport in the placenta. Eur J Immunol, 29, 733–44.
Environment Protection Agency (EPA) (1999). Estimating radiogenic cancer risks. Addendum – uncertainty analysis. EPA Report 402-R-99-003. US EPA, Office of Radiation and Indoor Air, Washington DC.
Evans HH, Mencl JJ, Ricanati M, Horng MF, Chaudry MA, Jiang Q, Hozier J and Liechty M (1996). Induction of multilocus mutations at the Tk1 locus after X irradiation of LS178Y cells at different times in the mitotic cycle. Radiat Res, 146, 131–8.
Fan YJ, Wang Z, Sadamoto S, Ninomiya Y, Kotomura N, Kamiya K, Dohi K, Kominami R and Niwa O (1995). Dose response of a radiation induction of a germline mutation at a hypervariable mouse minisatellite locus. Int J Radiat Biol, 68, 177–83.
Faraggi M, Gardin I, Stievenart JL, Bok BD and Le Guludec D (1998). Comparison of cellular and conventional dosimetry in assessing self-dose and cross-dose delivered to the cell nucleus by electron emissions of 99mTc, 123I, 111In, 67Ga and 201Tl. Eur J Nucl Med, 25, 205–14.
Food Standards Agency (FSA) (2001). Report of the Consultative Exercise on Dose Assessments. FSA, London.
Frolen H (1970). Genetic effects of strontium-90 at various stages of spermatogenesis in mice. Acta Radiol, 9, 596–608.
Gadbois DM, Crissman HA, Nastasi A, Habbersett R, Wang S, Chen D and Lehnert BE (1996). Alterations in the progression of cells through the cell cycle after exposure to alpha particles or gamma rays. Radiat Res, 146, 414–24.
Gapanovich VN, Iaroshevich RF, Shuvaeva LP, Becker SI, Nekolla EA and Kellerer AM (2001). Childhood leukaemia in Belarus before and after the Chernobyl accident: continued follow-up. Radiat Environ Biophys, 40, 259–67.
Gardner MJ, Snee MP, Hall AJ, Powell CA, Downes S and Terrell JD (1990). Results of case–control study of leukaemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria. BMJ, 300, 423–9.
Ghiassi-nejad M, Mortazavi SM, Cameron JR, Niroomand-rad A, and Karam PA (2002). Very high background radiation areas of Ramsar, Iran: preliminary biological studies. Health Phys, 82, 87–93.
Gibson BE, Eden OB, Barrett A, Stiller CA and Draper GJ (1988). Leukaemia in young children in Scotland. Lancet, ii, 630.
Gilbert ES, Cross FT and Dagle GE (1996). Analysis of lung tumor risks in rats exposed to radon. Radiat Res,145, 350–60.
Gilbert ES, Koshurnikova NA, Sokolnikov M, Khokhryakov VF, Miller S, Preston DL, et al (2000). Liver cancers in Mayak workers. Radiat Res, 154, 246–52.
Goddu SM, Howell RW and Rao DV (1996). Calculation of equivalent dose for Auger electron emitting radionuclides distributed in human organs. Acta Oncol, 35, 909–16.
Goodhead DT (1987). Relationship of microdosimetric techniques to applications in biological systems. In: The Dosimetry of Ionizing Radiation, Volume II (eds KR Kase, BE Bjarngard and FH Attix). Academic Press, New York, pp 1–89.
Goossens LHJ, Harrison JD, Kraan BCP, Cooke RM, Harper FT and Hora SC (1997). Probabilistic Accident Consequence Uncertainty Analysis: Uncertainty Assessment for Internal Dosimetry. Volumes 1 and 2. Joint Report of the US Nuclear Regulatory Commission and Commission of the European Communities. EUR 16773, Brussels.
Goossens LHJ, Wakeford R, Little M, Muirhead C, Hasemann I and Jones AJ (2000). Probabilistic accident consequence uncertainty analysis of the late health effects module in the COSYMA package. Radiat Prot Dosim, 90, 359–64.
Gössner W (2001). Target cells for internal dosimetry. Radiat Prot Dosim, 105, 39–42.
Gragtmans NJ, Myers DK, Johnson JR, Jones AR and Johnson LD (1984). Occurrence of mammary tumours in rats after exposure to tritium beta rays and 200 kVp X-rays. Radiat Res, 99, 636–650.
Greaves MF (1997). Aetiology of acute leukaemia. Lancet, 349, 344–9.
Grosche B, Lackland D, Mohr L, Dunbar J, Nicholas J, Burkart W and Hoel D (1999). Leukaemia in the vicinity of two tritium-releasing nuclear facilities: a comparison of the Kruemmel Site, Germany, and the Savannah River Site, South Carolina, USA. J Radiol Prot, 19, 243–52.
Guizard A-V, Boutou O, Pottier V, Troussard X, Pheby D, Launoy G, et al (2001). The incidence of childhood leukaemia around the La Hague nuclear waste reprocessing plant (France): a survey for the years 1978–1998. J Epidemiol Community Health, 55, 469–74.
Hakulinen T, Andersen A, Malker B, Pukkala E, Schou G and Tulinius H (1986). Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries. Acta Pathol Microbiol Immunol Scand Suppl, 288, 1–151.
Hall EJ (1999). Radiation carcinogenesis; will ‘how’ help to tell us ‘how much’? In: Eleventh International Congress of Radiation Research. Dublin, International Association for Radiation Research.
Hall EJ (2000). Radiobiology for the Radiologist. Philadelphia, Lippincott, Williams Wilkins.
Hall P, Adami HO, Trichopoulos D, Pedersen NL, Lagiou P, Ekbom A, et al (2004). Effect of low doses of ionising radiation in infancy on cognitive function in adulthood: Swedish population based cohort study. BMJ, 328, 19–21.
Hansen NE, Karle H and Jensen OM (1983). Trends in the incidence of leukemia in Denmark, 1943–77: an epidemiologic study of 14,000 patients. J Natl Cancer Inst, 71, 697–701.
Harrison JD and Muirhead CR (2003). Quantitative comparisons of cancer induction in humans by internally deposited radionuclides and external radiation. Int J Radiat Biol, 79, 1–13.
Harrison JD, Khursheed A, Phipps AW, Goossens L, Kraan B and Harper F (1998). Uncertainties in biokinetic parameters and dose coefficients determined by expert judgement. Radiat Prot Dosim, 79, 355–8.
Harrison JD, Leggett RW, Nosske D, Paquet F, Phipps AW, Taylor DM and Metivier H (2001). Reliability of the ICRP’s dose coefficients for members of the public, II. Uncertainties in the absorption of ingested radionuclides and the effect on dose estimates. Radiat Prot Dosim, 95, 295–308.
Harrison JD, Khursheed A and Lambert B (2002). Uncertainties in dose coefficients for intakes of tritiated water and organically bound forms of tritium by members of the public. Radiat Prot Dosim, 98, 299–311.
Haynes R and Bentham G (1995). Childhood leukaemia in Great Britain and fallout from nuclear weapons testing. J Radiol Prot, 15, 37–43.
Heady JA (1958). False figuring: statistical method in medicine. Med World, 89, 305–14.
Health and Safety Executive (HSE) (1993). Investigation of Leukaemia and Other Cancers in the Children of Male Workers at Sellafield. HSE, London.
Health and Safety Executive (HSE) (1994). Investigation of Leukaemia and Other Cancers in the Children of Male Workers at Sellafield: Review of the Results Published in October 1993. HSE, London.
Henshaw DL, Allen JE, Keitch PA, Salmon PL and Oyedepo C (1995). The microdistribution of polonium-210 with respect to bone surfaces in adults, children and fetal tissues at natural exposure levels. In: Health Effects of Internally Deposited Radionuclides: Emphasis on Radium and Thorium (eds G van Kaick, A Karaoglou and AM Kellerer). World Scientific, Singapore, pp 23–6.
Herskind C, Loncol Th and Höver K-H (2002). Spatial variation of radiation quality during moving beam therapy with 14 MeV [d(0.25)+T] neutrons. Radiat Prot Dosim, 99, 365–8.
Heston JF, Kelly JB, Meigs JW and Flannery JT (1986). Forty-five Years of Cancer Incidence in Connecticut: 1935–79. National Cancer Institute Monograph 70 (March 1986). National Cancer Institute, Bethesda MD.
Hill AB (1930). Sickness among operatives in Lancashire spinning mills. Industrial Health Research Board Report No. 59. HMSO, London.
Hill AB (1962). J Inst Actu, 88, 178.
Hill AB (1965). The environment and disease: association or causation? Proc R Soc Med, 58, 295–300.
Hjalmars U, Kulldorff M and Gustafsson G (1994). Risk of acute childhood leukaemia in Sweden after the Chernobyl reactor accident. BMJ, 309, 154–7.
Hodgson JT, Osman J, Varney E and Furness BJ (1994). The Gardner hypothesis. Cancer not linked to radiation or chemicals. BMJ, 308, 60.
Hofer KG (1998). Biophysical aspects of Auger processes – a review. Acta Oncol, 35, 789–96.
Hoffmann W (2002). Has fallout from the Chernobyl accident caused childhood leukaemia in Europe? A commentary on the epidemiologic evidence. Eur J Public Health, 12, 72–6.
Howell RW (1992). Radiation spectra for Auger-electron emitting radionuclides. Report No. 2 of AAPM Nuclear Medicine Task Group No. 6. Med Phys, 19, 1371–83.
Howell RW, Rao DV, Hou DY, Narra YR and Sastry KSR (1991). The question of relative biological effectiveness and quality factor for Auger emitters incorporated into proliferating mammalian cells. Radiat Res, 128, 282–92.
Howell RW, Narra VR, Sastry KSR and Rao DV (1993). On the equivalent dose for Auger electron emitters. Radiat Res, 134, 71–8.
International Agency for Research on Cancer (2001). IARC Monographs on the Evaluation of Carcinogenic Risk to Humans, Volume 78, Ionizing Radiation, Part 2: Some Internally Deposited Radionuclides. IARC Press, Lyon.
International Commission on Radiation Units and Measurements (ICRU) (1971). Radiation Quantities and Units. ICRU Report 19. Washington DC.
International Commission on Radiation Units and Measurements (ICRU) (1983). Microdosimetry. ICRU Report 36. ICRU, Bethesda MD.
International Commission on Radiation Units and Measurements (ICRU) (1986). The Quality Factor of Radiation. ICRU Report 40. Bethesda MD.
International Commission on Radiological Protection (ICRP) (1979). Limits for intakes of radionuclides by workers. ICRP Publication 30, Part 1. Ann ICRP, 2(3/4).
International Commission on Radiological Protection (ICRP) (1989). Age-dependent doses to members of the public from intakes of radionuclides: Part 1. ICRP Publication 56. Ann ICRP,
International Commission on Radiological Protection (ICRP) (1991). 1990 recommendations of the
International Commission on Radiological Protection. ICRP Publication 60. Ann ICRP, 21(1–3).
International Commission on Radiological Protection (ICRP) (1993). Age-dependent doses to members of the public from intakes of radionuclides: Part 2. Ingestion dose coefficients. ICRP Publication 67. Ann ICRP, 23(3/4).
International Commission on Radiological Protection (ICRP) (1994a). Human respiratory tract model for radiological protection. ICRP Publication 66. Ann ICRP, 24(1–3).
International Commission on Radiological Protection (ICRP) (1994b). Dose coefficients for intakes of radionuclides by workers. ICRP Publication 68. Ann ICRP, 24(4).
International Commission on Radiological Protection (ICRP) (1995a). Age-dependent doses to members of the public from intakes of radionuclides: Part 3. Ingestion dose coefficients. ICRP Publication 69. Ann ICRP, 25(1).
International Commission on Radiological Protection (ICRP) (1995b). Age-dependent doses to members of the public from intakes of radionuclides: Part 4. Inhalation dose coefficients. ICRP Publication 71. Ann ICRP, 25(3–4).
International Commission on Radiological Protection (ICRP) (1996). Age-dependent doses to members of the public from intakes of radionuclides: Part 5. Compilation of ingestion and inhalation dose coefficients. ICRP Publication 72. Ann ICRP, 26(1).
International Commission on Radiological Protection (ICRP) (2001). Doses to the embryo and fetus from intakes of radionuclides by the mother. ICRP Publication 88. Ann ICRP, 31(1–3).
International Commission on Radiological Protection (ICRP) (2003). Relative biological effectiveness (RBE), quality factor (Q), and radiation weighting factor (wR). ICRP Publication 92. Ann ICRP, 33(4).
Ivanov E, Tolochko GV, Shuvaeva LP, et al (1998). Infant leukemia in Belarus after the Chernobyl accident. Radiat Environ Biophys, 37, 53–5.
Jeffreys AJ and Neumann R (1997). Somatic mutation processes at a human minisatellite. Hum Mol Genet, 6, 129–32, 134–6.
Jeffreys AJ and Dubrova YE (2001). Monitoring spontaneous and induced human mutation by RAPD-PCR: a responsive to Weinberg et al (2001). Proc R Soc Lond B Biol Sci, 268, 2493–4.
Jeffries AJ, Tamaki K, MacLeod A, Monckton DG, Neil DL and Armour JA (1994). Complex gene conversion events in germline mutation at human minisatellites. Nat Genet, 6, 136–45.
Johnson JR, Myers DK, Jackson JS, Dunford DW, Gragtmans NJ, Wyatt HM, Jones AR and Percy DH (1995). Relative biological effectiveness of tritium for induction of myeloid leukaemia. Radiat Res, 144, 82–9.
Kadhim MA, Macdonald DA, Goodhead DT, Lorimore SA, Marsden SJ and Wright EG (1992). Transmission of chromosomal instability after plutonium alpha-particle irradiation. Nature, 355, 738–40.
Kadhim MA, Marsden SJ, Goodhead DT, Malcolmson AM, Folkard M, Prise KM and Michael BD (2001). Long-term genomic instability in human lymphocytes induced by single-particle irradiation. Radiat Res, 155, 122–6.
Katz R and Cucinotta FA (2003). Low fluence. Adv Space Res, 31, 1553–6.
Kinlen LJ (1988). Evidence for an infective cause of childhood leukemia: comparison of a Scottish new town with nuclear reprocessing sites in Britain. Lancet, ii,1323–7.
Kinlen LJ (1995). Epidemiological evidence for an infective basis in childhood leukaemia. Br J Cancer, 71, 1–5.
Kinlen L (2000). Infection, childhood leukaemia and the Seascale cluster. Radiol Prot Bull, No. 226, 9–18.
Kinlen LJ and John SM (1994). Wartime evacuation and mortality from childhood leukaemia in England and Wales in 1945–9. BMJ, 309, 1197–202.
Kinlen LJ, Hudson CM and Stiller CA (1991). Contacts between adults as evidence for an infective origin of childhood leukaemia: an explanation for the excess near nuclear establishments in west Berkshire? Br J Cancer, 64, 549–54.
Kinlen LJ, O’Brien F, Clarke K, Balkwill A and Matthews F (1993). Rural population mixing and childhood leukaemia: effects of the North Sea oil industry in Scotland, including the area near Dounreay nuclear site. BMJ, 306, 743–8.
Kinlen LJ, Dickson M and Stiller CA (1995). Childhood leukaemia and non-Hodgkin’s lymphoma near large rural construction sites, with a comparison with Sellafield nuclear site. BMJ, 310, 763–8.
Kiuru A, Auvinen A, Luokkamaki M, Makkonen K, Veidebaum T, Tekkel M, Rahu M, Hakulinen T, Servomaa K, Rytomaa T and Mustonen R (2003). Hereditary minisatellite mutations among the offspring of Estonian Chernobyl cleanup workers. Radiat Res, 159, 651–5.
Kodaira M, Satoh C, Hiyama K and Toyama K (1995). Lack of effects of atomic bomb radiation on genetic instability of tandem repetitive elements in human germ cells. Am J Hum Genet, 57, 1275–83.
Koshurnikova NA, Gilbert ES, Sokolnikov M, Khokhryakov VF, Miller S, Preston DL, et al (2000). Bone cancers in Mayak workers. Radiat Res, 154, 237–45.
Kovalchuk O, Dubrova YE, Arkhipov A, Hohn B and Kovalchuk I (2000). Wheat mutation rate after Chernobyl. Nature, 407, 583–4.
Kovalchuk O, Kovalchuk I, Arkhipov A, Hohn B and Dubrova YE (2003). Extremely complex pattern of microsatellite mutation in the germline of wheat exposed to the post-Chernobyl radioactive contamination. Mutat Res, 525, 93–10.
Kreisheimer M, Sokolnikov ME, Koshurnikova NA, Khokhryakov VF, Romanow SA, Shilnikova NS, et al (2003). Lung cancer mortality among nuclear workers of the Mayak facilities in the former Soviet Union. An updated analysis considering smoking as the main confounding factor. Radiat Environ Biophys, 42, 129–35.
Laurier D and Bard D (1999). Epidemiologic studies of leukemia among persons under 25 years of age living near nuclear sites. Epidemiol Rev, 21, 188–206.
Laurier D, Grosche B and Hall P (2002). Risk of childhood leukaemia in the vicinity of nuclear installations – findings and recent controversies. Acta Oncol, 41, 14–24.
Leggett RW (2001). Reliability of the ICRP’s dose coefficient for members of the public. I. Sources of uncertainty in the biokinetic models. Radiat Prot Dosim, 95, 199–213.
Leggett RW (2003). Reliability of the ICRP’s dose coefficient for members of the public. III. Plutonium as a case study of uncertainties in the systemic biokinetics of radionuclides. Radiat Prot Dosim, 106, 103–20.
Leggett RW, Bouville A and Eckerman KF (1998). Reliability of the ICRP’s systemic biokinetic models. Radiat Prot Dosim, 79, 335–42.
Lehnert BE, Valdez, YE and Stewart CC (1986). Translocation of particles to the tracheobronchial lymph nodes after lung deposition: kinetics and particle-cell relationships. Exp Lung Res, 10, 245–66.
Linke P, Clarkin KC and Wahl GM (1997). p53 mediates permanent arrest over multiple cell cycles in response to ?-irradiation. Cancer Res, 57, 1171–9.
Little JB (1998). Radiation-induced genomic instability. Int J Radiat Biol, 74, 663–71.
Little JB (2002). Comments on the paper of Nakanishi et al. Int J Radiat Biol, 78, 441–3.
Little JB (2003). Genomic instability and radiation J Radiol Prot, 23, 173–81.
Little JB, Azzam EI, de Toledo SM and Nagasawa H (2002). Bystander effects: intercellular transmission of radiation damage signals. Radiat Prot Dosim, 99, 159–62.
Little MP (2002). Absence of evidence for differences in the dose–response for cancer and noncancer endpoints by acute injury status in the Japanese atomic-bomb survivors. Int J Radiat Biol, 78, 1001–10.
Livshits LA, Malyarchuk SG, Kravchenko SA, Matsuka GH, Lukyanova EM, Antipkin YG, Arabskaya LP, Petit, E, Giraudeau F, Gourmelon P, Vergnaud G and Le Guen B (2001). Children of Chernobyl cleanup workers do not show elevated rates of mutations in minisatellite alleles. Radiat Res, 155, 74–80.
Lloyd F (1999). Leukaemia Occurrence near Coastal Features. Report Submitted in Partial Fulfilment for the Degree of Bachelor of Science in Clinical Sciences. Division of Clinical Sciences, School of Medicine, University of Leeds.
Lloyd F, Gilman EA, Law GR and Cartwright RA (2002). Leukaemia incidence near coastal features. J Public Health Med, 24, 255–60.
Lloyd RD, Taylor GN, Angus W, et al (1993). Bone cancer occurrence among beagles given 239Pu as young adults. Health Phys, 64, 45–51.
Lohrer H, Braselmann H, Richter H, Jackl G, Herbeck J, Hieber L, Kellerer A and Bauchinger M (2001). Instability of microsatellites in radiation-associated thyroid tumours with short latency periods. Int J Radiat Biol, 77, 891–9.
Lorimore SA and Wright EG (2003). Radiation-induced genomic instability and bystander effects: related inflammatory-type responses to radiation-induced stress and injury? A review. Int J Radiat Biol, 79, 15–25.
Luning KG, Frolen H, Nelson A and Ronnback C (1963a). Genetic effects of strontium-90 injected into male mice. Nature, 197, 304–5.
Luning KG, Frolen H, Nelson A and Ronnback C (1963b). Genetic effects of strontium-90 in immature germ cells in mice. Nature, 199, 303–4.
Luning KG, Frolen H and Nilsson A (1976). Genetic effects of 239Pu sale injections in male mice. Mutat Res, 34, 539–42.
Makrigiorgos GM, Adelstein SJ and Kassis AI (1989). Limitation of conventional internal dosimetry at the cellular level. J Nucl Med, 30, 1856–65.
Makrigiorgos GM, Baranowska-Kortylewicz J, Van den Abbeele AD, Ito S, Vinter DW, Adelstein SJ and Kassis AI (1990a). Microscopic spatial inhomogeneity of radiopharmaceutical deposition in mammalian tissues: dosimetry at the cellular level and comparison with conventional dosimetry. Radiat Prot Dosim, 31, 319–24.
Makrigiorgos GM, Adelstein SJ and Kassis AI (1990b). Cellular radiation dosimetry and its implications for estimation of radiation risks. Illustrative results with technetium-99m-labeled microspheres and macroaggregates. J Am Med Assoc, 264, 592–5.
Mangano JJ (1997). Childhood leukaemia in US may have risen due to fallout from Chernobyl. BMJ, 314, 1200.
May CA, Tamaki K, Neumann R, Wilson G, Zagars G, Pollack A, Dubrova YE, Jeffreys AJ and Meistrich ML (2000). Minisatellite mutation frequency in human sperm following radiotherapy. Mutat Res, 453, 67–75.
Miller RC, Geard CR, Geard MJ and Hall EJ (1992). Cell-cycle-dependent radiation-induced oncogenic transformation of C3H 10T1/2 cells. Radiat Res, 130, 129–33.
Moestrup SK, Birn H, Fischer PB, Petersen CM, Verroust PJ, Sim RB, Christensen EI and Nexo E (1996). Megalin-mediated endocytosis of transcobalamin-vitamin-B12 complexes suggests a role of the receptor in vitamin-B12 homeostasis. Proc Natl Acad Sci USA, 93, 8612–17.
Morgan WF (2003a). Non-targeted and delayed effects of exposure to ionizing radiation: I. Radiation-induced genomic instability and bystander effects in vitro. Radiat Res, 159, 567–80.
Morgan WF (2003b). Non-targeted and delayed effects of exposure to ionizing radiation: II. Radiation-induced genomic instability and bystander effects in vivo, clastogenic factors and transgenerational effects. Radiat Res, 159, 581–96.
Morgan WF, Day JP, Kaplan MI, McGhee EM and Limoli CL (1996). Genomic instability induced by ionizing radiation. Radiat Res, 146, 247–58.
Morrey M, Brown J, Williams JA, Crick MJ, Simmonds, JR and Hill MD (1988). A preliminary assessment of the radiological impact of the Chernobyl reactor accident on the population of the European Community. Report EUR 11523. Commission of the European Communities, Luxembourg.
Mothersill C and Seymour C (2001). Radiation-induced bystander effects: past history and future directions. Radiat Res, 155, 759–67.
Moysich KB, Menezes RJ and Michalek AM (2002). Chernobyl-related ionising radiation exposure and cancer risk: an epidemiological review. Lancet Oncol, 3, 269–79.
Muirhead CR, Goodill AA, Haylock RGE, Vokes J, Little MP, Jackson DA, O’Hagan JA, Thomas JM, Kendall GM, Silk TJ, Bingham D and Berridge GLC (1999). Occupational radiation exposure and mortality: second analysis of the National Registry for Radiation Workers. J Radiol Prot, 19, 3–26.
Nakanishi M, Tanaka K, Shintani T, Takahashi T and Kamada N (1999). Chromosomal instability in acute myelocytic leukaemia and myelodysplastic syndrome patients among atomic bomb survivors. J Radiat Res (Tokyo), 40, 159–67.
Nakanishi M, Tanaka K, Takahashi T, Kyo T, Dohy H, Fujiwara M and Kamada N (2001). Microsatellite instability in acute myelocytic leukaemia developed from A-bomb survivors. Int J Radiat Biol, 77, 687–94.
National Council on Radiation Protection and Measurements (NCRP) (1979). Tritium and other radionuclide labelled organic compounds incorporated in genetic material. NCRP Report 63. Bethesda MD.
National Council on Radiation Protection and Measurements (NCRP) (1997). Uncertainties in fatal cancer risk estimates used in radiation protection. NCRP Report 126. Bethesda MD.
National Council on Radiation Protection and Measurements (NCRP) (2001). Liver cancer risk from internally-deposited radionuclides. NCRP Report 135. Bethesda, MD.
National Research Council (NRC) (1980). Committee on the Biological Effects of Ionizing Radiation. The Effects on Populations of Exposure to Low Levels of Ionizing Radiation. BEIR III. National Academy Press, Washington DC.
National Research Council (NRC) (1990). Committee on Biological Effects of Ionizing Radiation. Health Effects of Exposure to Low Levels of Ionizing Radiation. BEIR V. National Academy Press, Washington DC.
National Research Council (NRC) (1999). Committee on Health Risks of Exposure to Radon. Health Effects of Exposure to Radon, BEIR VI. National Academy Press, Washington DC.
Naylor GPL, Bonas HE, Haines JW, Ham GJ, Harrison JD, Sandaram S and Dayan AD (1991). The gastrointestinal absorption and tissue distribution of alpha-emitting actinide isotopes and polonium- 210. British Nuclear Energy Society Conference: Occupational Radiation Protection, Guernsey. Thomas Telford, London, pp 291–6.
Neel JV (1999). Two recent radiation-related genetic false alarms; leukemia in West Cumbria, England and minisatellite mutations in Belarus. Teratology, 59, 302–6.
Nikjoo HP, O’Neill DT, Goodhead DT and Terrissol M (1997). Computational modelling of low energy electron-induced DNA damage by early physical and chemical events. Int J Radiat Biol, 71, 467–83.
Nikjoo H, O’Neill P, Wilson WE and Goodhead DT (2001). Computational approach for determining the spectrum of DNA damage by ionising radiation. Radiat Res, 156, 577–83.
Nilsson A, Bierke P, Walinder G and Broome-Karlsson A (1980). Age and dose related carcingenicity of 90Sr. Acta Radiol Oncol, 19, 223–8.
Noshchenko AG, Moysich KB, Bondar A, Zamostyan PV, Drosdova VD and Michalek AM (2001). Patterns of acute leukaemia occurrence among children in the Chernobyl region. Int J Epidemiol, 30, 125–9.
Noshchenko AG, Zamostyan PV, Bondar OY and Drozdova VD (2002). Radiation-induced leukemia risk among those aged 0–20 at the time of the Chernobyl accident: a case–control study in the Ukraine. Int J Cancer, 99, 609–18.
Oberdörster G (1988). Lung clearance of inhaled insoluble and soluble particles. J Aerosol Med, 1, 289–330. O’Donnell, Mitchell PI, Priest ND, Strange L, Fox A, Henshaw DL and Long SC (1997). Variations in the concentration of plutonium, strontium-90 and total alpha-emitters in human teeth collected within the British Isles. Sci Tot Environ, 201, 235–43.
Oghiso Y and Yamada Y (2000). Pathogenic process of lung tumors induced by inhalation exposures of rats to plutonium dioxide aerosols. Radiat Res, 154, 253–260.
Omar RZ, Barber JA and Smith PG (1999). Cancer mortality and morbidity among plutonium workers at the Sellafield plant of British Nuclear Fuels. Br J Cancer, 79, 1288–301.
Pacifici GM and Nottoli R (1995). Placental transfer of drugs administered to the mother. Clin Pharmacokinet, 28, 235–69.
Pampfer S and Streffer C (1989). Increased chromosome aberration levels in cells from mouse fetuses after zygote X-irradiation. Int J Radiat Biol, 55, 85–92.
Parkin DM, Clayton D, Black RJ, Masuyer E, Friedl HP, Ivanov E, Sinnaeve J, Tzvetansky CG, Geryk E, Storm HH, Rahu M, Pukkala E, Bernard JL, Carli PM, L’Huilluier, MC, Menegoz F, Schaffer P, Schraub S, Kaatsch P, Michaelis J, Apjok E, Schuler D, Crosignani P, Magnani C, Terracini B, Stengrevics A, Kriauciunas R, Coebergh JW, Langmark F, Zatonski W, Tulbure R, Boukhny A, Merabishvili V, Piesko I, Kramarova E, Pompe-Kirn V, Barlow L, Enderlin F, Levi F, Raymond L, Schuler G, Torhorsi J, Stiller CA, Sharp L and Bennett BG (1996). Childhood leukaemia in Europe after Chernobyl: 5 year follow-up. Br J Cancer, 73, 1006–12.
Pazzaglia S, Saran A, Pariset L, Rebessi S, Di Major V, Coppola M and Covelli V (1996). Sensitivity of C3H 10T1/2 cells to radiation-induced killing and neoplastic transformation as a function of cell cycle. Int J Radiat Biol, 69, 57–65.
Petridou E, Trichopoulos D, Dessypris N, Flytzani V, Haidas S, Kalmanti M, Koliouskas D, Kosmidis H, Piperopoulou F and Tzortzatou F (1996). Infant leukaemia after in utero exposure to radiation from Chernobyl. Nature, 382, 352–3.
Petrushkina NP, Kuropatenko ES, Okatenko PV, Kiryanov AG, Kabirova NR and Koshurnikova NA (2000). Childhood mortality in the city located near the nuclear complex ‘Mayak’. In: Proceedings of the 10th International Congress of the International Radiation Protection Association (IRPA10), Hiroshima, 2000. Paper P-2a-77. International Radiation Protection Association (http://www.irpa.net/irpa10/cdrom/00484.pdf).
Pierce DA and Preston DL (2000). Radiation-related cancer risks at low doses among atomic bomb survivors. Radiat Res, 154,178–86.
Pils S, Müller W-U and Streffer C (1999). Lethal and teratogenic effects in two successive generations of the HLG mouse strain after radiation exposure of zygotes – association with genomic instability? Mutat Res, 429, 85–92.
Pobel D and Viel J-F (1997). Case–control study of leukaemia among young people near La Hague nuclear reprocessing plant: the environmental hypothesis revisited. BMJ, 314, 101–6.
Pohl-Ruling J and Fischer P (1979). The dose–effect relationship of chromosome aberrations to alpha and gamma irradiation in a population subjected to an increased burden of natural radioactivity. Radiat Res, 80, 61–81.
Pohl-Ruling J, Haas OA, Obe G, Brogger A, Roscher U, Daschil F, Atzmuller C and Natarajan AT (1990). The Chernobyl fallout in Salzburg/Austria and its effect on blood chromosomes. Acta Biol Hung, 41, 215–22.
Pohl-Ruling J, Haas O, Brogger A, Obe G, Lettner H, Daschil F, Atzmuller C, Lloyd D, Kubiak R and Natarajan AT (1991). The effect on lymphocyte chromosomes of additional radiation burden due to fallout in Salzburg (Austria) from the Chernobyl accident. Mutat Res, 262, 209–17.
Polednak AP (2001). Cancer Incidence in Connecticut, 1980–1998. Connecticut Department of Public Health, Hartford CT.
Polednak AP (2003). Personal Communication Giving Additional Data from the Connecticut Tumor Registry, 30 May 2003.
Pollycove M and Feinendegen LE (2001). Biologic responses to low doses of ionizing radiation: detriment versus hormesis. J Nucl Med, 42, 17N–32N.
Ponnaiya B, Cornforth MN and Ullrich RL (1997). Radiation-induced chromosomal instability in BALB/c and C57BL/6 mice: the difference is as clear as black and white. Radiat Res, 147, 121–5.
Popplewell DS, Ham GJ, Johnson TE and Barry SF (1985). Plutonium in autopsy tissues in Great Britain. Health Phys, 49, 304–9.
Popplewell DS, Ham GJ, McCarthy W and Morgan M (1989). Isotopic composition of plutonium in human tissue samples determined by mass spectrometry. Radiat Prot Dosim, 26, 313–16.
Preston DL, Shimizu Y, Pierce DA, Suyama A and Mabuchi K (2003). Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and non-cancer disease mortality: 1950–1997. Radiat Res, 160, 381–407.
Preston RJ (2003). The LNT model is the best we can do – today. J Radiol Prot, 23, 263–8.
Prosser SL, McCarthy W and Lands C (1994). The plutonium content of human fetal tissue and implications for fetal dose. Radiat Prot Dosim, 55, 49–55.
Purnell SJ, Allen JE, Oyedepo C and Henshaw DL (1999). Fetal dosimetry from natural alpha particle emitters. Radiat Res, 152, S133–6.
Raabe OG, Book SA, Parks NJ, Chrisp CE and Goldman M (1981). Lifetime studies of 226Ra and 90Sr toxicity in beagles – a status report. Radiat Res, 86, 515–28.
Rao DV, Govelitz GF and Sastry KSR (1983). Radiotoxicity of thallium-201 in mouse testes: inadequacy of conventional dosimetry. J Nucl Med, 34, 145–53.
Redpath JL and Sun C (1990). Sensitivity of human hybrid cell line (HeLa X skin fibroblast) to radiation-induced neoplastic transformation in G2, M and mid-G1 phases of the cell cycle. Radiat Res, 121, 206–11.
Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, et al (1995). Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res, 141, 259–77.
Rooney C, Beral V, Maconochie N, Fraser P and Davies G (1993). Case–control study of prostatic cancer in employees of the United Kingdom Atomic Energy Authority. BMJ, 307, 1391–7.
Rowland RE (1994). Radium in Humans: A Review of US Studies. Argonne National Laboratory, Idaho.
Royal Society Working Group on the Health Hazards of Depleted Uranium Munitions (2001). The Health Hazards of Depleted Uranium Munitions, Part I. The Royal Society, London.
Royal Society Working Group on the Health Hazards of Depleted Uranium Munitions (2002). The Health Hazards of Depleted Uranium Munitions, Part II. The Royal Society, London.
Small Area Health Statistics Unit (SAHSU) (2001). The Small Area Health Statistics Unit (SAHSU) Rapid Enquiry Facility (RIF) Study on Bradwell, North Essex and Ward Analysis 1995–99. North Essex Health Authority, Witham.
Small Area Health Statistics Unit (SAHSU) (2002). SAHSU RIF Report on Bradwell North Essex: Ward Analysis 1995–99 S821. North Essex Health Authority, Witham.
Sanders CL, Lauhala KE and McDonald KE (1993). Lifespan studies in rats exposed to 239PuO2 aerosols. III Survival and lung tumours. Int J Radiat Biol, 64, 417–30.
Sastry KSR (1992). Biological effects of the Auger emitter 125I: a review. Report No. 1 of AAPM Nuclear Medicine Task Group No. 6. Med Phys, 19, 1361–70.
Savell J, Rao S, Pledger WJ and Wharton W (2001). Permanent growth arrest in irradiated human fibroblasts. Radiat Res, 155, 554–63.
Seymour CB and Mothersill C (2000). Relative contribution of bystander and targeted cell killing to the low-dose region of the radiation dose–response curve. Radiat Res, 153, 508–11.
Sharp L, Black RJ, Harkness EF and McKinney PA (1996). Incidence of childhood leukaemia and non-Hodgkin’s lymphoma in the vicinity of nuclear sites in Scotland, 1968–93. Occup Environ Med, 53, 823–31.
Shilnikova NS, Preston DL, Ron E, Gilbert ES, Vassilenko EK, Romanov SA, Kuznetsova IS, Sokolnikov ME, Okatenko PV, Kreslov VV and Koshurnikova NA (2003). Cancer mortality risk among workers at the Mayak nuclear complex. Radiat Res, 159, 787–98.
Sikov MR (1987). Placental transfer of the actinides and related heavy metals. In: Age-related Factors in Radionuclide Metabolism and Dosimetry (eds GB Gerber, H Metivier and H Smith). Martinus Nijhoff, Lancaster pp 303–14.
Simmons JA (1992). Absorbed dose – an irrelevant concept for irradiation with heavy charged particles? J Radiol Prot, 12, 173–9.
Simmons JA and Richards SR (1989). Microdosimetry of alpha-irradiated parenchymal lung. In: Low Dose Radiation (eds K Baverstock and JW Stather). Taylor & Francis, London.
Simon SL, Till JE, Lloyd RD, Kerber RL, Thomas DC, Preston-Martin S, et al (1995). The Utah leukemia case–control study: dosimetry methodology and results. Health Phys, 68, 460–71.
Snow J (1855). On the Mode of Communication of Cholera. 2nd ed. John Churchill, New Burlington Street, London. Reprinted in Snow on Cholera (1936) (ed WH Frost), published by The Commonwealth Fund, New York.
Stather JW (1993). Radiation carcinogenesis – past, present and future. In: Proceedings of an NEA Workshop. Radiation Protection on the Threshold of the 21st Century, Paris, January 1993. NEA/OECD, Paris, pp 21–37.
Stather JW, Clarke RH and Duncan KP (1988). The Risk of Childhood Leukaemia Near Nuclear Establishments. NRPB-R215. National Radiological Protection Board, Chilton.
Steiner M, Burkart W, Grosche B, Kaletsch U and Michaelis J (1998). Trends in infant leukaemia in West Germany in relation to in utero exposure due to the Chernobyl accident. Radiat Environ Biophys, 37, 87–93.
Sternglass EJ (1969). Has nuclear testing caused infant deaths? New Sci, 43, 178–81.
Stevens W, Thomas DC, Lyon JL, Till JE, Kerber RA, Simon SL, et al (1990). Leukemia in Utah and radioactive fallout from the Nevada test site. A case–control study. J Am Med Assoc, 264, 585–91.
Steward JA and John G (2001). An ecological investigation of the incidence of cancer in Welsh children for the period 1985–1994 in relation to residence near the coastline. J R Statist Soc A, 164, 29–43.
Steward JA, Adams-Jones D, Beer H and John G (1999). Results of a preliminary study to test the Irish Sea proximity hypothesis of Busby et al. Welsh Cancer Intelligence and Surveillance Unit, Cardiff.
Stewart AM and Kneale GW (2000). A-bomb survivors: factors that may lead to a re-assessment of the radiation hazard. Int J Epidemiol, 29, 708–14.
Stokke T, Oftedal P and Pappas A (1968). Effects of small doses of radioactive strontium on the rat bone marrow. Acta Radiol, 7, 321–9.
Stradling GN, Ham GJ, Smith H, Cooper J and Breadmore SE (1978a). Factors affecting the mobility of plutonium-238 dioxide in the rat. Int J Radiat Biol, 34, 37–47.
Stradling GN, Loveless BW, Ham GJ and Smith H (1978b). The biological solubility in the rat of plutonium present in mixed plutonium–sodium aerosols. Health Phys, 35, 229–35.
Straume T (1993). Tritium risk assessment. Health Phys, 65, 673–82.
Straume T and Carsten AL (1993). Tritium radiobiology and relative biological effectiveness. Health Phys, 65, 657–72.
Sullivan MF (1980). Absorption of actinide elements from the gastrointestinal tract of neonatal animals. Health Phys, 38, 173–85.
Tanooka H (2001). Threshold dose–response in radiation carcinogenesis: an approach from chronic beta-irradiation experiments and a review of non-tumour doses. Int J Radiat Biol, 77, 541–50.
Tauchi H, Nakamura N and Sawada S (1993). Cell cycle dependence for the induction of 6-thioguanine-resistant mutations: G2/M state is distinctively sensitive to 252Cf neutrons but not to 60Co gamma rays. Int J Radiat Biol, 63, 475–81.
Thomas RG (1994). The US radium luminisers, a case for a policy of ‘below regulatory concern’. J Radiol Prot, 14, 141–53.
Tondel M, Carlsson G, Hardell L, Eriksson M, Jakobsson S, Flodin U, Skoldestig A and Axelson O (1996). Incidence of neoplasms in ages 0–19 y in parts of Sweden with high 137Cs fallout after the Chernobyl accident. Health Phys, 71, 947–50.
Ueno AM, Furuno-Fukushi I and Matsudaira H (1989). Cell killing and mutation to 6-thioguanine resistance after exposure to tritiated amino acids and tritiated thymidine in cultured mammalian cells. In: Tritium Radiobiology and Health Physics (ed S Okada). Proceedings 3rd Japanese–US Workshop, Nagoya University, Japan. IPPJ-REV-3, pp 200–210.
United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) (1988). Sources, Effects and Risks of Ionizing Radiation. 1988 Report to the General Assembly, with Annexes. United Nations, New York.
United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) (1994). Sources and Effects of Ionizing Radiation. 1994 Report to the General Assembly, with Scientific Annexes. United Nations, New York.
United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) (2000). Sources and Effects of Ionizing Radiation. 2000 Report to the General Assembly, with Scientific Annexes. United Nations, New York.
Urquhart JD, Black RJ, Muirhead MJ, Sharp L, Maxwell M, Eden OB and Adams Jones D (1991). Case–control study of leukaemia and non-Hodgkin’s lymphoma in children in Caithness near the Dounreay nuclear installation. BMJ, 302, 687–92.
US Department of Health, Education & Welfare (1964). Smoking and Health. Public Health Service Publication No. 1103. Washington DC.
Voelz GL, Lawrence JNP and Johnson ER (1997). Fifty years of plutonium exposure to the Manhattan Project plutonium workers. Health Phys, 61, 181–90.
Wakeford R (2002). Infant leukaemia in Wales after the Chernobyl accident. Energy Environ, 13, 294–97.
Wakeford R and Little MP (2003). Risk coefficients for childhood cancer after intrauterine irradiation: a review. Int J Radiat Biol, 79, 293–309.
Waker AJ, Schrewe U, Burmeister J, Dubeau J and Surette RA (2002). Classical microdosimetry in radiation protection dosimetry and monitoring. Radiat Prot Dosim, 99, 311–16.
Wang PP and Haines CS (1995). Childhood and adolescent leukaemia in a North American population. Int J Epidemiol, 24, 1100–109.
Wartenberg D, Schneider D and Brown S (2004). Childhood leukaemia incidence and the population mixing hypothesis in US SEER data. Br J Cancer, 90, 1771–6.
Watson GE, Lorimore SA, Clutton SM, Kadhim MA and Wright EG (1997). Genetic factors influencing alpha-particle-induced chromosomal instability. Int J Radiat Biol, 71, 497–503.